Rare cancer diagnoses surge dramatically among millennials, Gen X
Diagnoses of appendix cancer have tripled in the US for people born between 1976 and 1984 — and it has quadrupled for those born between 1981 and 1989.
Advertisement
The study was published on Monday in the Annals of Internal Medicine.
Researchers from the Vanderbilt University Medical Center analyzed data from the National Cancer Institute's Surveillance, Epidemiology and End Results (SEER) Program to arrive at these findings.
'When you take these alarming rates that we are seeing for appendiceal cancer across generations, together with the fact that one in every three patients diagnosed with appendiceal cancer is diagnosed under the age of 50, these point to a timely need for everyone to be aware of the signs and symptoms of appendix cancer,' said lead author Andreana Holowatyj, PhD, assistant professor of Medicine at Vanderbilt University Medical Center and Vanderbilt-Ingram Cancer Center, in a press release from the university.
Cancer of the appendix is rare, affecting only about one or two people per million each year in the US, according to the National Cancer Institute (NCI). Even so, doctors emphasize the importance of seeking medical attention if symptoms emerge.
Advertisement
3 Appendix cancer has been rising among members of Generation X and millennials.
Chinnapong – stock.adobe.com
'Ruling out the possibility of an appendix cancer diagnosis, or diagnosing it early, is important for this cancer as we continue to learn what factors may be contributing to this worrisome trend,' Holowatyj said.
Appendiceal cancer forms in the appendix, which is a small organ located in the lower right abdomen.
There are two main types: epithelial appendiceal cancer, which involves the cells of the lining of the appendix, and neuroendocrine appendiceal cancer, which results from the growth of neuroendocrine (carcinoid) tumors of the appendix, the NCI states.
Advertisement
In early stages of the disease, most people do not notice symptoms.
3 The rates have tripled in the US among people born between 1976 and 1984 — while quadrupling for those born between 1981 and 1989.
Peakstock – stock.adobe.com
As the cancer progresses, common symptoms include pain, a bloated feeling, a mass in the abdomen, nausea and vomiting, and sudden feelings of fullness while eating, according to the above source.
Common treatments for this type of cancer include surgery to remove the appendix and any other affected organs, as well as chemotherapy to kill any metastasized cancer cells.
Advertisement
Based on the study findings, the researchers are calling for increased awareness among both the public and the medical community.
'As incidence rates in younger generations are often indicative of future disease burden, these results support the need for histology-specific investigations of appendiceal adenocarcinoma, as well as increased education and awareness of appendiceal adenocarcinomas among healthcare providers and the public,' the study stated.
3 Annals of Internal Medicine published the study on Monday, as researchers from Vanderbilt University Medical Center analyzed data from the National Cancer Institute's Surveillance Epidemiology and End Results (SEER) Program.
charnsitr – stock.adobe.com
There are no standard screening guidelines or risk factors for appendix cancer, which means up to half of diagnoses occur after the disease has already spread, according to the researchers.
Five-year survival rates for appendix cancer range from 10% to 63%.
The new study received funding from the Appendix Cancer Pseudomyxoma Peritonei (ACPMP) Research Foundation and the National Institutes of Health.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Medscape
an hour ago
- Medscape
Weight Loss Diet Not Needed With Exercise for Hip OA Pain
A very-low-calorie diet and weight loss combined with exercise does not appear to offer any greater reductions in hip osteoarthritis (OA) pain compared to exercise alone, even in people who are overweight or obese. Overweight and obesity are considered risk factors for hip OA, yet there are conflicting data on whether weight loss reduces the need for hip joint replacement, researchers wrote in their August 4, 2025, report published in Annals of Internal Medicine . In this study, researchers randomly assigned 101 people in Australia with a BMI above 27 to either 1) a dietitian-supported ketogenic very low-calorie diet plus a home-based exercise program supported by regular physiotherapy consultations or 2) the exercise program alone for 6 months . All the participants were aged 50 years or older, had experienced significant hip pain for at least 3 months, and had radiographic evidence of femoral or acetabular osteophytes and joint space narrowing. Despite the very-low-calorie-diet group losing a mean 8.5% more body weight than the exercise-only group, the study found no significant difference between the two groups in the primary outcome of hip pain severity at 6 or 12 months. However, both groups did show a clinically significant reduction in hip pain severity at 6 months: a 2-point reduction on an 11-point scale in the exercise-only group and 2.8-point reduction in the diet plus exercise group. More people in the diet-plus-exercise group achieved a clinically relevant reduction in hip pain severity at 6 months than in the exercise-only group. The study also found that those in the diet group had greater improvements in hip-related quality of life at 6 months compared to the exercise-only group, which persisted to 12 months. Physiotherapist and study co-author Kim Bennell, PhD, director of the Centre for Health, Exercise and Sports Medicine at the University of Melbourne, Australia, said while the association between weight and symptoms or progression was strong with knee OA, there hadn't been many high-quality randomized controlled trials of weight loss for hip OA. 'The knee is not the hip; you can't necessarily generalize results from the knee to the hip,' Bennell told Medscape . 'We thought that it may not be as effective as you find at the knee because there may be different factors driving at the hip; biomechanical factors might be more important.' Could the Results Direct Patients to Seek Surgery Sooner? An accompanying editorial by rheumatologist Gillian Hawker, MD, of Women's College Hospital in Toronto and exercise physiologist Kristine Godziuk, PhD, of the University of California, San Francisco, raised the question of whether the use of pharmacotherapies for weight loss, such as the GLP-1 receptor agonists, might influence outcomes through changes in body composition. Bennell said further studies were needed to explore whether greater weight loss than was achieved in this study might have led to better outcomes and over a longer period. Commenting on the findings, rheumatologist Nancy E. Lane, MD, endowed professor of medicine and rheumatology and director of the Center for Musculoskeletal Health at UC Davis Health, Sacramento, California, said hip OA was much more related to underlying structural abnormalities than other forms of OA. 'There's no therapy that can make it better, because the hip joint, the shape of the hip — either the femoral head or the acetabular cup — is off and it's worn out,' Lane said to Medscape . 'There's no therapy for osteoarthritis of the hip, once it becomes painful.' While weight loss would help to place less stress on the joint, it is a much smaller issue than for other joints, and being overweight in and of itself is not a risk factor for hip replacement, Lane said. 'It was really important to know that this type of exercise and weight loss wasn't going to have an effect on the hip,' she said, pointing out that this knowledge might help people with hip OA to get surgical treatment sooner, rather than being told to lose weight first. 'But to be very clear, that that's not the case in other joints, such as the knee, where these interventions make a difference,' she said.
Yahoo
2 hours ago
- Yahoo
As more young people get screened, more colon cancer is being found early. Here's how to lower your risk
Even more colorectal cancer cases are being found in adults under 50, and a new collection of research suggests that a surge in screening may be tied to many of the more recent diagnoses – but not the overall trend. In 2018, the American Cancer Society updated its guidelines for colon and rectal cancer screening, recommending that adults at average risk get screened starting at age 45 – earlier than 50, which was previously advised. Then, in 2021, the US Preventive Services Task force also lowered the recommended age to start screening for colon and rectal cancers from 50 to 45. The shift in screening guidelines is associated with a recent increase in early-stage colorectal cancer diagnoses, but it does not explain the rise among younger adults in general – a trend that began in the mid-1990s and includes late-stage cancers, as well. Colorectal cancer refers to colon cancer, which starts in the colon, and rectal cancer, which starts in the rectum. 'The drivers of rising incidence are still unknown, but many research efforts are ongoing, with investigations covering the gamut from microplastics to ultra processed food and many other gut exposures introduced in the last half of the 20th century, when this began,' Elizabeth Schafer, associate scientist of surveillance and health equity science at the American Cancer Society, said in an email. Lowering the screening age 'has likely facilitated earlier detection of cancers that might have been missed,' but there is still more work to do to identify the driving factors behind the ongoing overall rise of colorectal cancer in younger ages, Dr. Joseph Rinaldi, a gastroenterologist at Montefiore Einstein Comprehensive Cancer Center, said in an email. 'It is likely that factors beyond screening guidelines are contributing to the overall rise in colorectal cancer incidence,' Rinaldi said. 'Much work remains to identify causal factors – whether environmental, genetic, or population-based – that can be targeted for prevention and, potentially, reversal of this trend.' Now, research conducted by the American Cancer Society that was published Monday in the medical journal JAMA found that the share of US adults ages 45 to 49 who are up to date on colorectal cancer screening climbed from 20.8% in 2019 and 19.7% in 2021 to 33.7% in 2023. 'We've been waiting for screening to take off in this age group,' Schafer, an author on the new screening study, said in the email. 'But the real thrill is the translation to early diagnosis, which means less intense treatment and lives saved.' A second study, also conducted by the American Cancer Society and published Monday in JAMA, found that the prevalence of early-stage colorectal cancer diagnoses among adults 45 to 49 increased from 9.4 cases per 100,000 people in 2019 to 11.7 per 100,000 in 2021 and then to 17.5 per 100,000 in 2022. That translates to a 50% relative increase between 2021 and 2022. 'If screening was the cause of the rise, the increase would have been for early- instead of late-stage disease,' said Schafer, lead author of the second paper. 'Local stage diagnosis was rare in this age group before screening because there are usually no symptoms yet,' Schafer said of early-stage cancers that have not spread to other parts of the body. 'So yes, it was a bit shocking, actually, to see early-stage incidence double from 9.4 to 17.5 per 100,000 in this newly screened group.' As a rise in colon and rectal cancers persists among younger adults, public health experts now urge them to know the warning signs and to get screened when eligible. The signs and symptoms to watch for More than half of the people who are diagnosed with colorectal cancer before 50 are not eligible for screening because they haven't yet reached the recommended age of 45. And most people who are eligible have still not been screened, said Jessica Star, associate scientist of cancer risk factors and screening surveillance research at the American Cancer Society, who was lead author on the new screening study and an author on the other paper. Whether someone is recommended for screening or not, they should still watch for signs and symptoms of colorectal cancer and talk with their doctor if they notice any, she said. In the United States, about 1 in 23 men and 1 in 25 women will be diagnosed with colorectal cancer in their lifetime. The most common symptom is rectal bleeding,' Star said in an email, adding that 41% of patients under 50 tend to experience this symptom, compared with 26% of patients older than 50. Many people also may have abdominal cramping or pain. 'Young people, especially, are reluctant to talk about these types of symptoms, but it could actually save their life,' Star said. 'Other important symptoms include a persistent change in bowel habits or the shape of stool, decreased appetite, and weight loss. People with any of these symptoms that persist for several weeks should be followed up with a doctor's visit,' she said. 'If you are young and your concerns are not being addressed, get a second opinion. There are too many stories about young people being told they have hemorrhoids, finding out months or years later that it is cancer.' When Kelly Spill, 33, experienced symptoms of colorectal cancer after the birth of her first child, she said, her doctors told her that they were tied to being postpartum and internal hemorrhoids. 'One day I went to the bathroom, and I looked down, and you would have thought it was my time of the month, and it most certainly was not. That's when it became extremely alarming,' Spill told CNN in May of the blood in her stool. When she noticed massive amounts of blood again, she took photos and showed them to a primary care physician. The doctor immediately ordered a colonoscopy, and that's what led to her being diagnosed with stage III rectal cancer at age 28 in 2020. 'To self-advocate is such a big one,' Spill said. 'If I didn't push, push, push, I don't know where I would be, and especially as a new mom.' Spill was treated with an immunotherapy drug called dostarlimab and is now a healthy mother of three. She remains cancer-free. How to reduce your risk Getting screened can help reduce the risk of colorectal cancer, because almost all colorectal cancers begin as precancerous polyps in the colon or rectum. But through screening, these polyps can be identified and removed before they turn cancerous. Current options for colorectal cancer screening for people at average risk include a stool-based fecal test either annually or every three years; a traditional colonoscopy every 10 years; a virtual colonoscopy every five years; or a sigmoidoscopy procedure, which involves using a tube-like instrument called an endoscope to examine the lower part of the colon, every five years. A separate study published Monday in JAMA found that when people newly eligible for screening were automatically mailed a fecal test kit at their home address without asking for it, they were more likely to complete screening than those who were asked to actively choose between a colonoscopy, a fecal test or deferring screening altogether. 'Another important question is how to get more people screened, especially people without access to healthcare, a group that had no significant increase in screening in our study,' Schafer, who was not involved in that study, said in the email. Despite recent increases in screening, it's still estimated that more than 1 in 3 adults 45 and older are not getting screened as recommended, according to the National Colorectal Cancer Roundtable. There are other steps people can take to help prevent colorectal cancer. 'There are many things people of all ages can do to reduce their risk, including not smoking, maintaining a healthy body weight, being physically active, avoiding excessive alcohol consumption, and eating a healthy diet that is low in red and processed meat and high in whole grains, fruits, and vegetables,' Star said. More than half of all colorectal cancers in the US are attributable to those modifiable risk factors, according to the American Cancer Society. 'There have been several studies that work to identify factors contributing to the development of colon cancer. Maintaining a physically active lifestyle and a healthy weight is important, as obesity has been linked to early-onset disease,' Rinaldi said. 'I also encourage avoiding tobacco, refined grains, and sugary beverages and instead focus on consuming a fiber-rich diet that is more plant-based and that limits the consumption of red and processed meats, as this is thought to be protective to colon health.' Solve the daily Crossword
Washington Post
12 hours ago
- Washington Post
After cancer diagnosis, out-of-pocket costs jump, study says
Out-of-pocket costs increased by an average of $592.53 per month in the six months after a cancer diagnosis, according to a recent study published in JAMA Network Open. The study analyzed a sample of over 46,000 patients from the Surveillance, Epidemiology and End Results (SEER) cancer registry, examining responses from 2008 to 2019. The sample consisted of both patients with and without cancer to provide a control group. Within the sample group, breast cancer was the most common form of cancer (74.1 percent), followed by colorectal (14.5 percent) and lung cancer (11.4 percent). On average, out-of-pocket costs rose by a cumulative total of $4,144.71. 'This difference, driven by the onset of cancer diagnosis and its associated treatment, underscores the financial burden of cancer care on patients with insurance who are not yet eligible for Medicare,' the authors write in the study. Cost also increased with stage of diagnosis. Patients with Stage 0 cancer saw an average increase of $462.01 per month, while Stage 4 patients' costs rose an average of $719.97 per month. The authors note that late-stage disease usually is associated with more treatment and higher medical expenditures. This study has implications for policy reform, the researchers argue. 'The variability in [out-of-pocket costs] based on cancer stage underscores the need for policies such as paid sick leave, that address both insurance continuity and financial assistance, especially for patients with more advanced cancer,' they write. — Hannah Docter-Loeb This article is part of The Post's 'Big Number' series, which takes a brief look at the statistical aspect of health issues. Additional information and relevant research are available through the hyperlinks.
